Aman Kamboj,Shaurya Dumka,Mumtesh Kumar Saxena,Yashpal Singh,Bani Preet Kaur,Severino Jefferson Ribeiro da Silva,Sachin Kumar
Abstract:Pig farming has become a strategically significant and economically important industry across the globe. It is also a potentially vulnerable sector due to challenges posed by transboundary diseases in which viral infections are at the forefront. Among the porcine viral diseases, African swine fever, classical swine fever, foot and mouth disease, porcine reproductive and respiratory syndrome, pseudorabies, swine influenza, and transmissible gastroenteritis are some of the diseases that cause substantial economic losses in the pig industry. It is a well-established fact that vaccination is undoubtedly the most effective strategy to control viral infections in animals. From the period of Jenner and Pasteur to the recent new-generation technology era, the development of vaccines has contributed significantly to reducing the burden of viral infections on animals and humans. Inactivated and modified live viral vaccines provide partial protection against key pathogens. However, there is a need to improve these vaccines to address emerging infections more comprehensively and ensure their safety. The recent reports on new-generation vaccines against swine viruses like DNA, viral-vector-based replicon, chimeric, peptide, plant-made, virus-like particle, and nanoparticle-based vaccines are very encouraging. The current review gathers comprehensive information on the available vaccines and the future perspectives on porcine viral vaccines.
What problem does this paper attempt to address?
The paper primarily explores the understanding, challenges, and future directions of viral vaccines for swine pathogens. Specifically, this review article aims to address the following key issues:
1. **Importance and Background**: With the growth of the global population and the increasing demand for meat, especially pork, the swine industry faces a significant economic burden from viral diseases. These diseases include African Swine Fever (ASF), Classical Swine Fever (CSF), Foot-and-Mouth Disease (FMD), Porcine Reproductive and Respiratory Syndrome (PRRS), Pseudorabies, Swine Influenza, and Transmissible Gastroenteritis (TGE).
2. **Role of Vaccines**: The article emphasizes the importance of vaccination as the most effective strategy for controlling and preventing animal viral diseases. From the era of Jenner and Pasteur to the development of modern novel vaccine technologies, vaccines have played a crucial role in reducing the burden of viral diseases in both animals and humans.
3. **Issues with Existing Vaccines**: Although inactivated vaccines and modified live virus vaccines can provide a certain degree of protection, they need improvement to more comprehensively address emerging infections and ensure their safety.
4. **Research Progress on New Vaccines**: The article reviews the latest research progress on new-generation vaccines for swine viruses (such as DNA vaccines, replicon vaccines based on viral vectors, chimeric vaccines, plant-manufactured vaccines, virus-like particle vaccines, and nanoparticle-based vaccines) and considers these advancements to be very encouraging.
5. **Vaccine Classification and Technology**: The article discusses in detail various types of vaccines, including whole microorganism vaccines, inactivated vaccines, attenuated live vaccines, marker vaccines, viral vector vaccines, and subunit vaccines, and analyzes the advantages and limitations of each type.
6. **Future Perspectives**: The article also looks ahead to the future development directions in the field of swine viral vaccines, including the development of new-generation vaccines using advances in molecular biology, improving vaccine delivery systems, and addressing the issue of differentiating infected from vaccinated animals (DIVA).
In summary, this paper aims to comprehensively review the current understanding of swine viral vaccines, identify the challenges faced, and propose possible solutions and development directions to promote more effective vaccine development and application.